Pachet de 10 flacoane6 în stocEconomisiți 25%PT-141 10 mg
Bremelanotidă, agonist melanocortic
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Numai pentru uz de cercetare. Acest compus se vinde strict pentru cercetare in vitro și scopuri de laborator și nu este destinat consumului uman sau uzului terapeutic. Prin cumpărare confirmi că ești un cercetător calificat și ești de acord cu declinarea noastră completă.
Mai sunt doar 6 pachete
Agonist sintetic al receptorilor melanocortinici studiat pentru efectele asupra căilor neurale asociate cu răspunsul sexual în aplicații de cercetare.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mecanism
Cercetarea sugerează agonismul primar al MC4R, cu efecte ale sistemului nervos central asupra markerilor neurochimici la subiecții de studiu.
Verificat HPLC față de o specificație de puritate ≥99%. Testat independent de laboratoare terțe acreditate.
PT-141 — întrebări frecvente
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Ghiduri legate de PT-141
Cercetătorii explorează și
RecomandatPachet de 10 flacoaneEconomisiți 17%HGH
Pulbere liofilizată10 IU · 4 strengths
Hormon de creștere uman recombinant
În 2 stack-uri
Pachet de 10 flacoaneEconomisiți 18%Tesamorelin
Pulbere liofilizată10 mg · 3 strengths
Analog GHRH stabilizat
În 1 stack
RecomandatPachet de 10 flacoaneEconomisiți 22%CJC-1295 + Ipamorelin
Pulbere liofilizată5 mg + 5 mg
Stack clasic analog GHRH + mimetic al ghrelinei
În 2 stack-uri